Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
A Multicenter, Randomized, Double-blinded, Parallel, Active-controlled, Phase III Clinical
Trial to Evaluate the Efficacy and Safety of DW-330SR2 and Pelubiprofen in Chronic Back Pain
Patients.